Publications by authors named "Andrew Trainer"

Claim this Profile
P
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Andrew F Trainer

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Andrew F Trainer

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Sam S Chang, Karim Chamie, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Andrew F Trainer

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
Karim Chamie, Sam S Chang, Eugene Kramolowsky, Mark L Gonzalgo, Piyush Kumar Agarwal, Andrew F Trainer

NEJM Evid· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results.
Kevin C Zorn, Mohamed Bidair, Andrew Trainer, Andrew Arther, Eugene Kramolowsky

BJUI Compass· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
K Kent Chevli, Neal D Shore, Andrew Trainer, Angela B Smith, Daniel Saltzstein

J Urol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer.
Barrett Cowan, Eric Klein, Ken Jansz, Karl Westenfelder, Timothy Bradford, Andrew Trainer

BJU Int· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.
Franciscus Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, Julia A Bridge, Donna J Mayne, Andrew F Trainer

Eur Urol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results.
Mihir Desai, Mo Bidair, Naeem Bhojani, Andrew Trainer, Andrew Arther

Can J Urol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial.
Peter Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark Sutton, Andrew Trainer

Can J Urol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trial.
Mihir Desai, Mo Bidair, Kevin C Zorn, Andrew Trainer, Andrew Arther

BJU Int· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results.
Naeem Bhojani, Mohamed Bidair, Kevin C Zorn, Andrew Trainer, Andrew Arther

Urology· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained.
Peter Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark Sutton, Andrew Trainer

Adv Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.
F Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, Julia A Bridge, Donna J Mayne, Andrew F Trainer

Eur Urol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial.
Mark Plante, Peter Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Andrew Trainer

BJU Int· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WATER II (80-150 mL) procedural outcomes.
Mihir Desai, Mo Bidair, Naeem Bhojani, Andrew Trainer, Andrew Arther

BJU Int· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.
Vignesh T Packiam, Donald L Lamm, Daniel A Barocas, Andrew Trainer, Benjamin Fand

Urol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia.
Peter Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark Sutton, Andrew Trainer

J Urol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic radical prostatectomy: initial 70 cases at a U.S. university medical center.
Douglas M Dahl, James O L'esperance, Andrew F Trainer, Zhong Jiang, Karen Gallagher

Urology· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis